RxDoctor Payments Data

Ian Behr

Surgery · Boston, MANPI 1740695980

Payments from drug & device makers

What this record shows

This record is dominated by grants: $50,000 of the $56,192 with a category attached, or 89.0%. Medtronic accounts for 89.0% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2020 at $50,000 and has fallen 90.8% since, to $4,601 in 2025. Among surgery clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$56,192in general payments, 2019–2025

Across 36 payments — averaging $1560.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$50K
  • Intuitive Surgical$5K
  • Stryker$538
  • Davol Inc.$244
  • BD$196
  • Mallinckrodt Enterprises LLC$121
  • plus $221 from 6 others

What the payments were for

  • Grants$50,00089%
  • Travel & lodging$4211%
  • Food & beverage$1,2712%
  • Education$4,5008%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$56,192 in reported general payments places this provider in the 95th percentile of 694 surgery providers in Massachusetts.

See all surgery providers in Massachusetts

Medicare billing

Part B allowed, 2024
$92,279
Medicare patients
185
Services billed
381

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levothyroxine Sodium58$577
Oxycodone Hcl70$149

Paid to pharmacies, not to this prescriber.

Other surgery in Boston

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →